Track the Navamedic ASA stock price and the full management transaction log of the company, a publicly traded company based in Norway. Shares are listed on NO NO, under the authority of Oslo Børs. Operating in the Health Care sector, Navamedic ASA has published 23 public disclosures. Market capitalisation: €405.3m. The latest transaction was disclosed on 26 June 2026 (Purchase). Among the most active insiders: Soleglad Invest AS. Every trade is free.
23
Insider Decl.
0
Thresholds
€67,956
17 ops.
Buy Volume
€29,381
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Navamedic ASA Strong Buy (bullish), based on 2 analysts. Average price target: NOK 23.50.
15Σ signal
Buys €67,956€29,381 Sells
Fundamental score
Ranked 20,527 of 25,936 companies
31.2
score / 100
Value
36
Quality
26
FCF yld5.7%
Earn yld-5.8%
EV/EBITDA20.9x
ROE-6.1%
Gross mgn39%
Net mgn-4.2%
Debt/EBITDA7.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Navamedic ASA is a Norwegian company focused on health and pharmaceuticals, providing pharmaceutical products and health solutions. It is listed on the Oslo Stock Exchange.